WHO ICTRP trial
Brazilian trial of Amantadine for disorders of consciousness after intracranial…
RBR-6789t4v · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Recruiting
Key facts
| Trial ID | RBR-6789t4v |
|---|---|
| Public title | Brazilian trial of Amantadine for disorders of consciousness after intracranial bleeding due to aneurysm rupture |
| Scientific title | Amantadine for disorders of consciousness after Aneurysmal Subarachnoid Hemorrhage |
| Primary sponsor | Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo |
| Secondary sponsors | Hospital Universitário Cajuru da Pontifícia Universidade Católica do Paraná |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Recruiting |
| Study type | Intervention |
| Phase | 2-3 |
| Countries | Brazil |
| Conditions | Subarachnoid hemorrhage;I51.6 |
| Interventions | This is a double-blinded, randomized controlled trial with two groups. Intervention group: 30 individuals with aneurysmal subarachnoid hemorrhage will receive amantadine, oral pills, administered for 6 weeks: 100mg in the morning in week 1… |
| Registration date | Jan 19, 2023 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: